Pfizer Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Pfizer Share Price

4,552.80-39.70 (-0.87%)

Live
As On: 10 Jun, 2026, 10:50 AM IST
As On: 10 Jun, 2026, 10:50 AM IST

Sector: Pharmaceuticals
Industry: Pharma - MNC

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	4,600.00
High	4,600.00
Low	4,552.40
Prev Close	4,592.50
Volume	2,975
VWAP(₹)	4,569.71

Key Metrics

PE Ratio(x)	28.92
EPS - TTM(₹)	157.92
MCap(₹ Cr.)	20,888.41
MCap Rank	27
PB Ratio(x)	23.32
Div Yield(%)	1.64
Face Value(₹)	10.00
52W High(₹)	5,993.00
52W Low(₹)	4,396.70
MCap/Sales	1.90
Beta(1 Month)	-0.21
BV/Share(₹)	196.97

Pfizer share price insights

Rank 453 - ET 5002021 ranking

Dividend Announcement
Company announced a dividend of Rs 75.0 per share on May 12, 2026 with record date of Jul 17, 2026.
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 10.35% outperformed its 3 year CAGR of 2.32%. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 14.6% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Pfizer Share Price Update
Pfizer Ltd. share price moved down by -0.87% from its previous close of Rs 4,592.50. Pfizer Ltd. stock last traded price is 4,552.80
Share Price Value
Today/Current/Last 4,552.804,553.00
Previous Day 4,592.504,586.20

Found Insights useful?

Pfizer Share Price Returns

1 Day	-0.87%
1 Month	-5.52%
3 Months	-5.22%
1 Year	-21.14%
3 Years	15.28%
5 Years	-17.8%

Pfizer Share Recommendations

Mean recosCurrent

BUY

5 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	3	3	3	2
Buy	1	1	1	1
Hold	1	1	1	2
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	5	5	5	5

Recent Recos

Target₹3830
OrganizationICICI Direct
HOLD

Target₹5250
OrganizationAnand Rathi
BUY

Target₹4505
OrganizationEmkay Global Financial Services
HOLD

View all Stock Recommendations

News & Analysis

View all Pfizer Share News & Announcements

Financials

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	683.24	684.19	670.22	636.49	580.75
Total Income Growth (%)	-0.14	2.08	5.30	9.60	-8.06
Total Expenses	489.30	426.69	407.44	208.00	406.80
Total Expenses Growth (%)	14.67	4.72	95.88	-48.87	-1.82
EBIT	193.94	257.50	262.78	428.49	173.95
EBIT Growth (%)	-24.68	-2.01	-38.67	146.33	-19.96
Profit after Tax (PAT)	141.84	189.02	191.75	330.94	127.60
PAT Growth (%)	-24.96	-1.42	-42.06	159.36	-19.42
EBIT Margin (%)	28.39	37.64	39.21	67.32	29.95
Net Profit Margin (%)	20.76	27.63	28.61	51.99	21.97
Basic EPS (₹)	31.01	41.32	41.91	72.34	27.89

Annual	FY 2008	FY 2007
Total Revenue	799.22	1,055.47
Total Revenue Growth (%)	-24.28	37.58
Total Expenses	591.89	588.70
Total Expenses Growth (%)	0.54	1.30
Profit after Tax (PAT)	299.57	340.00
PAT Growth (%)	-11.89	219.75
Operating Profit Margin (%)	28.27	63.45
Net Profit Margin (%)	40.85	46.22
Basic EPS (₹)	100.38	113.93

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	2,453.60	2,373.68	2,525.81	2,673.64	2,319.67
Total Revenue Growth (%)	3.37	-6.02	-5.53	15.26	-0.69
Total Expenses	1,610.32	1,635.56	1,734.80	1,900.75	1,650.95
Total Expenses Growth (%)	-1.54	-5.72	-8.73	15.13	-2.49
Profit after Tax (PAT)	767.60	551.33	623.93	612.56	497.61
PAT Growth (%)	39.23	-11.64	1.86	23.10	-2.26
Operating Profit Margin (%)	37.33	34.35	33.17	30.00	30.54
Net Profit Margin (%)	33.64	25.13	25.73	23.46	22.22
Basic EPS (₹)	136.46	120.51	128.50	133.89	108.77

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 10.35% outperformed its 3 year CAGR of 2.32%. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 14.6% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)

Annual	FY 2008	FY 2007
Total Assets	1,100.65	871.97
Total Assets Growth (%)	26.23	34.53
Total Liabilities	199.56	222.25
Total Liabilities Growth (%)	-10.21	-8.32
Total Equity	901.09	649.72
Total Equity Growth (%)	38.69	60.14
Current Ratio (x)	5.04	3.59
Total Debt to Equity (x)	0.00	0.00
Contingent Liabilities	68.69	105.72

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	4,911.11	4,228.78	4,000.73	3,900.51	3,265.90
Total Assets Growth (%)	16.14	5.70	2.57	19.43	-25.87
Total Liabilities	693.70	633.24	793.43	1,036.10	872.86
Total Liabilities Growth (%)	9.55	-20.19	-23.42	18.70	-13.57
Total Equity	4,217.41	3,595.54	3,207.30	2,864.41	2,393.04
Total Equity Growth (%)	17.30	12.10	11.97	19.70	-29.52
Current Ratio (x)	6.17	5.07	3.84	2.81	2.49
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	364.73	533.83	437.83	338.14	254.98

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2008	FY 2007
Net Cash flow from Operating Activities	237.76	16.45
Net Cash used in Investing Activities	-78.87	232.53
Net Cash flow from Financing Activities	-95.20	-75.90
Net Cash Flow	63.69	173.09
Closing Cash & Cash Equivalent	543.61	479.91
Closing Cash & Cash Equivalent Growth (%)	13.27	56.41
Total Debt/ CFO (x)	0.00	0.00

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	659.75	256.84	355.68	667.08	427.33
Net Cash used in Investing Activities	-71.34	53.70	-36.05	-575.02	-468.84
Net Cash flow from Financing Activities	-205.34	-235.14	-345.79	-180.51	-1,571.07
Net Cash Flow	383.07	75.40	-26.16	-88.45	-1,612.58
Closing Cash & Cash Equivalent	495.07	112.00	36.60	62.76	151.21
Closing Cash & Cash Equivalent Growth (%)	342.03	206.01	-41.68	-58.49	-91.43
Total Debt/ CFO (x)	0.00	0.01	0.01	0.00	0.01

All figures in Rs Cr, unless mentioned otherwise

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 237.76 cr is 0.79 times compared to the reported net profit of Rs 299.57 cr. (Source: Consolidated Financials)
Increase in Cash from Investing
Company has used Rs 561.67 cr for investing activities which is an YoY increase of 687.31%. (Source: Standalone Financials)

Annual	FY 2008	FY 2007
Return on Equity (%)	33.24	52.33
Return on Capital Employed (%)	22.93	71.34
Return on Assets (%)	27.21	38.99
Interest Coverage Ratio (x)	0.00	0.00
Asset Turnover Ratio (x)	66.61	84.36
Price to Earnings (x)	4.66	5.68
Price to Book (x)	1.55	2.97
EV/EBITDA (x)	3.90	3.05
EBITDA Margin (%)	29.79	64.75

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	18.20	15.33	19.45	21.38	20.79
Return on Capital Employed (%)	19.61	20.46	24.05	25.70	27.44
Return on Assets (%)	15.62	13.03	15.59	15.70	15.23
Interest Coverage Ratio (x)	108.50	52.94	67.95	85.64	45.26
Asset Turnover Ratio (x)	0.50	0.53	0.61	0.73	68.54
Price to Earnings (x)	23.87	34.84	25.45	32.57	41.67
Price to Book (x)	4.34	5.34	4.94	6.95	8.64
EV/EBITDA (x)	17.01	21.01	15.38	20.34	24.67
EBITDA Margin (%)	39.99	37.19	37.52	34.40	35.43

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
Heikin-Ashi Changeover
Bullish indication on daily chart
Prev. Close Price
4536.35
LTP
4552.80
Formed on:

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Pfizer	28.88	23.16	33.24	22.93	27.21	2.32	28.27	40.85	100.38	5.04	0.00	0.00
Abbott India	36.45	11.85	32.50	41.87	23.87	9.36	30.36	22.39	730.36	2.55	0.00	0.00
GSK Pharma	35.81	16.36	45.68	54.54	23.95	5.71	36.32	27.10	61.15	2.03	0.00	0.00
AstraZeneca	113.11	24.30	21.48	26.00	9.42	30.47	11.51	8.24	75.01	1.77	0.00	0.00
Sanofi Consumer Healthcare India Ltd.	42.15	28.31	62.52	75.41	43.89	16.85	35.94	27.33	104.27	3.85	0.00	0.00
Add More

Annual Ratios (%)

Choose from Peers

P&G Health
Sanofi India

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Found Peer Comparison useful?

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 2,92,43,042 63.92 % 0.00
Pledge 0 0.00 % 0.00
FII 12,86,831 2.80 % 0.09
DII 77,20,161 16.86 % -0.16
MF 52,70,095 11.52 % -0.19
Others 74,97,698 16.42 % 0.07
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 63.92 63.92 63.92 63.92
Pledge 0.00 0.00 0.00 0.00
FII 2.80 2.71 2.60 2.40
DII 16.86 17.03 17.09 17.21
Mutual Funds 11.52 11.71 11.74 11.70
Others 16.42 16.34 16.39 16.47

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Nippon India Small Cap Direct-G
Equity: Small Cap
4
- 568.15
  Amount Invested (in Cr.)
- 0.78%
  % of AUM
- 0.00
  % Change (MoM basis)
Quant Small Cap Direct-G
Equity: Small Cap
3
- 430.80
  Amount Invested (in Cr.)
- 1.418323%
  % of AUM
- 0.00
  % Change (MoM basis)
ICICI Pru Value Direct-G
Equity: Value Oriented
5
- 363.53
  Amount Invested (in Cr.)
- 0.61007364%
  % of AUM
- 116.40
  % Change (MoM basis)

View all Mutual Fund Schemes

Pfizer Top Searches

Corporate Actions

Recent
General Meeting
-
May 12, 2026
Final
750%
May 12, 2026
Board Meeting
Audited Results & Final Dividend
May 06, 2026

Announced on	Meeting on
May 06, 2026	May 12, 2026
Audited Results & Final Dividend
Jan 30, 2026	Feb 09, 2026
Quarterly Results
Nov 03, 2025	Nov 12, 2025
Quarterly Results
Aug 07, 2025	Aug 13, 2025
Quarterly Results
May 19, 2025	May 19, 2025
Audited Results & Special Dividend

Dividends
Announced on Ex-Date Dividend%
May 12, 2026 Jul 17, 2026 750%
May 20, 2025 Jul 09, 2025 1300%
May 19, 2025 Jul 09, 2025 350%
May 17, 2024 Aug 21, 2024 350%
May 16, 2023 Aug 11, 2023 50%

Announced on	Ex-Date
May 25, 2000	Jun 12, 2000
Bonus Ratio: 1 share(s) for every 1 shares held
Jul 25, 1977	-
Bonus Ratio: 4 share(s) for every 5 shares held
Jul 25, 1972	-
Bonus Ratio: 2 share(s) for every 5 shares held
	-
Bonus Ratio: 1 share(s) for every 2 shares held

Splits
No Data Available
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
May 12, 2026 Jul 28, 2026
-
May 19, 2025 Jul 21, 2025
-
Aug 09, 2024 Aug 28, 2024
-
Feb 29, 2024 Apr 02, 2024
-
Dec 07, 2023 Jan 09, 2024
-

About Pfizer

Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 21,009.65 Crore) operating in Pharmaceuticals sector.

Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Scrap for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs 669.95 Crore, down 1.95 % from last quarter Total Income of Rs 683.24 Crore and up 5.26 % from last year same quarter Total Income of Rs 636.49 Crore. Company has reported net profit after tax of Rs 199.82 Crore in latest quarter.

The company’s top management includes Mr.Pradip Shah, Ms.Meenakshi Nevatia, Mr.Amit Agarwal, Mr.P Rengan, Mr.Lakshmanan Krishnakumar, Ms.Meena Ganesh, Ms.Sonia Singh, Mr.Prajeet Nair. Company has Walker Chandiok & Co. LLP as its auditors. As on 31-03-2026, the company has a total of 4.57 Crore shares outstanding.

Pfizer Share Price Today is Rs. 4552.80. On previous day, the Pfizer Share Price (NSE) closed at Rs. 4527.9, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 63.92% of the stake in Pfizer shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Pfizer stocks was 2.81% as compared to 2.71% in Dec 2025 with increase of 0.1%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 16.87% as compared to 17.03% in Dec 2025 with decrease of 0.16%. Out of the total DII holdings in Pfizer shares 11.52% was held by mutual funds. The rest including public held is 16.4%. Pfizer stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Pfizer Dividend: Ever since 1950, Pfizer dividends has been paid out around 37 times. As on 10 Jun, 2026, 10:50 AM IST, The overall dividend yield for Pfizer stands at 1.63%. The last dividend paid was on July 17, 2026 (Rs. 75.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 157.92.

Pfizer Bonus: The most recent bonus issue had been in year June 12, 2000 around 25 years ago at 1 : 1 ratio. The first bonus issue was announced in Jul 1968.

Stock Forecast:
After showing 669.95 Cr. of sales and 1.95% of quarterly net loss, there have been multiple ups and downs in the Pfizer stock prices in the past few weeks. For example, Pfizer stock price on 2nd of June 2026 was around Rs. 4514.5. Pfizer share price now stands at an average of Rs. 4552.80. Judging by last week's performance, stock is in up trend.

Pfizer has a median target price of Rs. 6033.2 in 12 months by 5 analysts. They have provided a high estimate of Rs. 7500.0 and low estimate of Rs. 5182.0 for Pfizer share.

Historical Prices and Performance:
Pfizer, incorporated in 1950 is a Mid Cap company (with a market cap of Rs. 21009.65) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Pfizer stock was 17.18%, 18.2%, 15.33%, 19.45% and 21.38% respectively.
The Pfizer share gave a 3 year return of 16.28% as compared to Nifty 50 which gave a return of 25.2%.
Pfizer announced 750.0% final dividend on July 17, 2026.

Key Metrics:
PE Ratio of Pfizer is 29.08
Prices/Sales Ratio of Pfizer is 1.9
Price/Book Ratio of Pfizer is 23.32

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Pfizer, major competitors and peers include Abbott India, GSK Pharma, AstraZeneca and Sanofi Consumer Healthcare India Ltd.. As of Dec 2025, the dividend yield of Pfizer stands at 1.63% while Abbott India, GSK Pharma, AstraZeneca and Sanofi Consumer Healthcare India Ltd. stand at 2.51%, 2.6%, 0.38% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 29.08 and 23.32 respectively.

Leadership of Pfizer :
Prajeet Nair is Director & Company Secretary
Pradip Shah is Chairman & Ind.Director
Meenakshi Nevatia is Managing Director
P Rengan is Executive Director - Operations
Amit Agarwal is Executive Director & CFO
Meena Ganesh is Independent Director
Lakshmanan Krishnakumar is Independent Director
Sonia Singh is Independent Director

Show More

Industry

Key Indices Listed On

Nifty 500, BSE 500, BSE 250 SmallCap Index, BSE SmallCap, BSE Healthcare

Address

The Capital,1802 / 1901, 18th Floor,Mumbai, Maharashtra - 400051

Contact

contactus.india@pfizer.com

http://www.pfizerltd.co.in

Executive Leadership

PS

Pradip Shah

Chairman & Ind.Director

MN

Meenakshi Nevatia

Managing Director

AA

Amit Agarwal

Executive Director & CFO

PR

P Rengan

Executive Director - Operations

Show More

Auditors

BSR & Co. LLP

Walker Chandiok & Co. LLP

FAQs about Pfizer share

1. What is Pfizer share price and what are the returns for Pfizer share?
Pfizer share price is Rs 4,552.80 as on 10 Jun, 2026, 10:50 AM IST. Pfizer share price is down by 0.87% based on previous share price of Rs. 4527.9.
2. What's the market capitalization of Pfizer?
Within the Pharmaceuticals sector, Pfizer stock has a market cap rank of 27. Pfizer has a market cap of Rs 20,888.41 Cr.
3. What are the returns for Pfizer share?
Return Performance of Pfizer Shares:
- 1 Week: Pfizer share price moved up by 1.96%
4. What is 52 week high/low of Pfizer share price?
Pfizer share price saw a 52 week high of Rs 5,993.00 and 52 week low of Rs 4,396.70.
5. What is the PE & PB ratio of Pfizer?
The PE ratio of Pfizer stands at 29.08, while the PB ratio is 5.0.

Top Gainers

As on 10:43 AM | 10 Jun 2026

1,231.00

81.91 (7.13%)

1,794.60

107.90 (6.40%)

2,378.30

123.11 (5.46%)

DOMS Industries

2,204.10

113.30 (5.42%)

Afcons Infrastru

332.30

16.81 (5.33%)

Top Losers

As on 10:43 AM | 10 Jun 2026

169.11

-8.90 (-5.00%)

Muthoot Finance

2,881.00

-110.10 (-3.69%)

Manappuram Finance

296.00

-11.25 (-3.67%)

1,038.60

-38.11 (-3.54%)

231.51

-8.31 (-3.47%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.